Skip to main content

Table 1 Patient characteristics before treatment

From: A pilot study: sequential gemcitabine/cisplatin and icotinib as induction therapy for stage IIB to IIIA non-small-cell lung adenocarcinoma

Variable

Median (range) or frequency (%)

Age (years)

55 (42 to 61)

Gender

 

 Male

5(45%)

 Female

6(55%)

Smoking status

 

 Current

4(36%)

 Former

1(9%)

 Never

6(55%)

Location of the primary tumor

 

 Central

2(18%)

 Peripheral

9(82%)

Biopsy method

 

 Bronchoscopy

3(27%)

 CT-guided needle biopsy

6(55%)

 EBUS-TBNA

2(18%)

NSCLC clinical stage

 

 IIB

2(18%)

 IIIA

9(82%)

  1. CT, computed tomography; EBUS-TBNA, endobronchial ultrasound-guided transbronchial needle aspiration; NSCLC, non-small-cell lung cancer.